Within the 3 months after vaccination, 8.6% of patients had anterior uveitis, and 1.6% nonanterior uveitis. The total rates ...

Uveitis, or inflammation of the eye's uvea area beneath the white of the eye, is a rare disease that has proven challenging ...

Uveitis is inflammation of the middle layer of the eye, or the uvea, and the surrounding tissue. It can cause pain, eye redness, and cloudy vision. The term “uveitis” refers to a range of ...

Uveitis is a rare inflammatory eye disease. Posterior and panuveitis in particular are associated with a poor prognosis and a ...

A recent population-based cohort study published in the Journal of American Medical Association in South Korea found ...

The odds of the condition were increased among recipients of all 4 vaccines studied: Pfizer, Moderna, AstraZeneca, and J&J.

The latest research report, “Uveitis Treatment Market”, covers various aspects of the industry, including market size, status, trends, and future insights for the next 10 years. It provides a detailed ...

Uveitis is uncommon in patients with multiple sclerosis (MS), but the link between the two entities is clearly established. While a common etiology or pathologic process remains unknown ...

Uveitis is certainly treatable and in most cases it is curable. However, there are certain causes of uveitis (such as autoimmune disease) that may require ongoing treatment since uveitis may recur ...

Uveitis is a rare inflammatory eye disease. Posterior and panuveitis in particular are associated with a poor prognosis and a ...

MS can cause a wide variety of neuro-ophthalmic manifestations and is also associated in some cases with uveitis. Intermediate uveitis, characterized by vitreous inflammation and peripheral ...